Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes.
NCT ID: NCT04183829
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20000 participants
OBSERVATIONAL
2019-06-01
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital
NCT04294212
Outpatient Service for Mid-trimester Termination of Pregnancy
NCT03346629
Medication Abortion for Pregnancy of Unknown Location
NCT04026789
Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia
NCT04602052
Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used.
NCT06140069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
induced termination of pregnancy
Medically, induced termination of pregnancy (I-TOP) is defined as an intervention to voluntarily terminate a pregnancy (ie, induced abortion) by either surgical or medical means so it does not result in a live birth.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* permanent population and no tendency to move.
* normal language expression and understanding ability, able to understand research content.
* be able and willing to provide written informed consent and effective contact information, and be willing to cooperate with follow-up investigations.
Exclusion Criteria
* with history of adverse pregnancy and childbirth
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Institute for Family Planning, China
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pei Kaiyan
Role: PRINCIPAL_INVESTIGATOR
National Research Institute for Family Planning (NRIFP)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Boai Hospital
Zhongshan, Guangdong, China
Zhangjiakou Maternal and Child Health Hospital
Zhangjiakou, Hebei, China
Daqing People's Hospital
Daqing, Heilongjiang, China
Changzhou Maternal and Child Health Hospital
Changzhou, Jiangsu, China
Yangzhou Maternal and Child Health Hospital
Yangzhou, Jiangsu, China
People's Hospital of Inner Mongolia Autonomous Region
Hohhot, Mongolia Autonomous, China
Qingdao Maternal and Child Health Hospital
Qingdao, Shandong, China
Zaozhuang Maternal and Child Health Hospital
Zaozhuang, Shandong, China
Taiyuan Maternal and Child Health Hospital
Taiyuan, Shanxi, China
Tanggu Maternal and Child Health Hospital
Tanggu, Tianjin Municipality, China
Chongqing Health Center for Women and Children
Chongqing, , China
Shenzhen Luohu Maternity and Child Healthcare Hospital
Shenzhen, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tu Pengcheng, M.D.
Role: primary
Tu Pengcheng, M.D.
Role: primary
Tu Pengcheng, M.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No.2018-I2M-1-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.